Menu

Canada Names Chief Science Advisor

Scientists speculate about whether the appointment will mean more funding for research.

Sep 27, 2017
Ashley P. Taylor

Mona NemerWIKIMEDIA, PHILLIP JEFFREYYesterday (September 26), Canada’s Prime Minister Justin Trudeau named Mona Nemer, a cardiology researcher and vice president of research at the University of Ottawa, as the nation’s chief science advisor, Science reports.

The science advisor, who will report to both Trudeau and Minister of Science Kirsty Duncan, is charged with advising government ministers on scientific matters, making government-funded science accessible to the public, and “protecting government scientists from being muzzled,” Science reports.

“I intend to conduct my work in an objective, impartial and open manner to provide the best possible advice,” Nemer tells The Globe and Mail. “I understand the credibility of the position and the benefit that it can provide to Canadians depends on how independent I am going to be.”

Nemer is a recipient of the Order of Canada, a national honor, and has won numerous awards for her research, which focuses on heart development and function, according to The Globe and Mail.

“Mona’s fantastic, she has a very good reputation among Canadian researchers and has had a long and productive career,” Jim Woodgett, director of research at the Lunenfeld-Tanenbaum Research Institute in Toronto, who knows Nemer well, tells Science. “In my interactions with her she has always listened, asked questions and then came to her own decisions, she’s not the kind of person who makes rash decisions,” he says.

Trudeau’s predecessor, Prime Minister Stephen Harper, eliminated the role in 2008. Trudeau fulfills a 2015 campaign promise in bringing it back. The reestablishment of the role is intended to respond to the demands of scientists who felt that the Harper administration ignored scientific evidence in policymaking and kept scientists from speaking out, according to Nature News.

Woodgett urges scientists not to expect Nemer to increase government funding for scientific research, something a Duncan-commissioned report from earlier this year recommended. “A lot of Canadian scientists have an unrealistic idea of the role. She’s not there to advocate for research funding, but to provide advice,” he tells Science.

Katie Gibbs, executive director of Evidence For Democracy, a group that advocates for evidence-based decision-making in government, is more optimistic. Gibbs notes that in a speech upon her appointment, Nemer spoke of wanting to make Canadian science the best in the world.

“I don’t see how we can do that without more funding,” Gibbs tells the National Observer. “So I think it was actually a really positive indication that her office is going to be taking on some of the issues around funding for research.”

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Best Practices: Calculating Cell Confluency
Best Practices: Calculating Cell Confluency
In this white paper, learn how to use a cell imager system to directly and accurately capture and calculate cell confluency!
LabTwin's AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
LabTwin's AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the lab. 
BCG Digital Ventures and Sartorius Help Launch the World's First Voice-powered Digital Assistant for Scientists
BCG Digital Ventures and Sartorius Help Launch the World's First Voice-powered Digital Assistant for Scientists
LabTwin GmbH, an independent company backed by Boston Consulting Group Digital Ventures (BCG Digital Ventures) and leading biopharma supplier, Sartorius, today announced the launch of the world's first voice and AI-powered digital lab assistant.
Understanding Transcriptomic or Proteomic Datasets to Reveal Biological Mechanisms
Understanding Transcriptomic or Proteomic Datasets to Reveal Biological Mechanisms
When analyzing large transcriptomics or proteomics datasets, we want to understand whether the phenomenon is unusual or commonplace and whether there are informative similarities to other areas of biology. To learn more about how Ingenuity Pathway Analysis (IPA®) and Analysis Match can help, download this white paper from QIAGEN!